platinum has been researched along with Leiomyosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Barker, HE; Barnett, S; Bedő, J; Caldwell, R; Carmagnac, A; Collins, IM; Dall, G; Dobrovic, A; Fox, SB; Grimmond, S; Hamilton, A; Hofmann, O; Kee, D; Klein, O; Kyran, EL; Lim, R; Lobley, A; McNally, O; Meniawy, T; Milesi, B; Nesic, K; Ng, AP; Nugawela, D; O'Grady, E; Olesen, I; Papadopoulos, L; Papenfuss, AT; Penington, J; Power, JD; Ratnayake, G; Scott, CL; Shield-Artin, K; Stewart, KP; Tan, TH; Tram, J; Vandenberg, CJ; Vissers, JHA; Wakefield, MJ; Zhou, W; Zhu, W | 1 |
1 other study(ies) available for platinum and Leiomyosarcoma
Article | Year |
---|---|
Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Topics: Female; Homologous Recombination; Humans; Leiomyosarcoma; Ovarian Neoplasms; Piperazines; Platinum; Poly(ADP-ribose) Polymerases; Recombinational DNA Repair; Uterine Neoplasms | 2023 |